Business Context and Reporting Period
Company: Carpenter Technology Corporation (CRS)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended June 30, 2026
Business Overview: A global producer and distributor of premium specialty alloys (titanium, nickel, cobalt, stainless steels) serving aerospace, defense, medical, energy, and industrial markets. Operations are organized into two segments: Specialty Alloys Operations (SAO) and Performance Engineered Products (PEP).
Leadership Change: Tony R. Thene returned as President and CEO effective July 26, 2026, following the passing of Brian J. Malloy.
Key Financial Metrics
| Metric ($ millions) | Fiscal 2026 | Fiscal 2025 | Fiscal 2024 |
|---|---|---|---|
| Net Sales | $3,124.2 | $2,877.1 | $2,759.7 |
| Operating Income | $702.0 | $521.8 | $323.1 |
| Net Income | $529.8 | $376.0 | $186.5 |
| Diluted EPS | $10.52 | $7.42 | $3.70 |
| Operating Margin | 22.5% | 18.1% | 11.7% |
| Adjusted Operating Margin (excl. surcharge) | 27.8% | 22.4% | 16.3% |
| Cash from Operations | $605.0 | $440.4 | $274.9 |
| Adjusted Free Cash Flow | $362.3 | $287.5 | $179.0 |
| Capital Expenditures | $242.7 | $154.3 | $96.6 |
| Total Debt | $690.7 | $695.4 | N/A |
| Cash & Equivalents | $393.3 | $315.5 | $199.1 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9% year-over-year, driven by a 15% increase in Aerospace and Defense sales and a 15% increase in Energy sales. This was partially offset by a 21% decline in Medical sales due to supply chain inventory management.
- Profitability: Operating income rose 35% to a record $702.0 million. The SAO segment delivered record operating income of $782.9 million (27.7% margin), driven by productivity gains and pricing realization.
- Debt Restructuring: The company issued $700.0 million in 5.625% Senior Notes due 2034 and used proceeds to redeem $700.0 million of prior notes (due 2028 and 2030). This resulted in a $15.6 million debt extinguishment loss but lowered the overall interest rate burden.
- Segment Performance: SAO sales grew 10% while PEP sales declined 6% due to lower Medical and Distribution volumes.
Guidance, Outlook, and Risks
- Capital Expenditures: Management expects fiscal 2027 capital expenditures to range between $355.0 million and $375.0 million, primarily driven by the brownfield expansion in Athens, Alabama.
- Share Repurchases: As of June 30, 2026, $119.0 million remained available under the existing $400.0 million program. In August 2026, the Board authorized an additional $1.0 billion repurchase program.
- Dividends: Quarterly dividend maintained at $0.20 per share.
- Key Risks:
- Raw Material Volatility: Reliance on nickel, cobalt, and titanium; prices are volatile, though surcharge mechanisms are used to pass costs to customers.
- Geopolitical Factors: Exposure to conflicts (e.g., Middle East, Ukraine) and trade tariffs impacting supply chains and demand.
- Cyclicality: Significant exposure to cyclical aerospace, defense, and energy markets.
- LIFO Accounting: Inventory is valued using LIFO; repeal of LIFO could result in a substantial one-time tax liability (estimated $432.6 million inventory increase if FIFO were used).
Investor Verification Checklist
- Debt Maturity Profile: Verify the impact of the new 2034 Notes on future interest expense and cash flow requirements.
- Medical Segment Recovery: Monitor the 21% decline in Medical sales to determine if it is a temporary inventory correction or a structural shift.
- Capital Project Execution: Track the progress and cost of the Athens, Alabama expansion against the $355M-$375M guidance for fiscal 2027.
- Raw Material Surcharges: Assess the lag effect between raw material cost increases and the ability to pass these costs through to customers via surcharges.
- Executive Transition: Evaluate the strategic direction under the new CEO leadership following the passing of the previous CEO.